Delivery Order SPE2DB24D1201-SPE2DB25FJBVZ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,993.56 firm fixed price delivery order is for the supply of Letrozole 2.5 mg tablets. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.81 firm fixed-price delivery order is for the supply of 4566491504 Letrozole 2.5 mg tablets. The contract has an ultimate completion date of November 20, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.98 firm fixed-price delivery order is for the supply of 4,567,558,074 units of the drug Letrozole 2.5 mg tablets in 90-count packages. The award has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,163.36 firm-fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,153.64, is a Firm Fixed Price Delivery Order for the supply of 90-count bottles of the prescription drug Letrozole 2.5 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,369.65 firm-fixed-price delivery order is for the purchase of 90-count tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,363.91 firm-fixed-price contract is for the delivery of 90 tablets of the medication Letrozole 2.5 mg. The contract has a completion date of May 28, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,489.40 firm fixed-price delivery order is for the supply of 90 tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of July 8, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $1,336.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of certain medical conditions. The contract is a delivery order with a firm fixed price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award, valued at $1,387.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Letrozole 2.5 mg tablets to the government. This delivery order contract is a firm fixed-price agreement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJBVZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.56 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. The contract has a completion date of March 13, 2025 and was awarded on March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/12/25 |